Consensus $5.27. The company said, "The company increased the lower end of its fiscal year 2023 diluted non-GAAP EPS guidance from the prior range of $5.25 to $5.30 to the new range of $5.28 to $5.30, which includes an estimated 21 cent unfavorable impact from foreign currency at rates as of the beginning of February."
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on MDT:
- Medtronic’s (NYSE:MDT) Decent Q3 Results Kindle Hope
- Medtronic reports third quarter fiscal 2023 financial results
- Medtronic receives CE Mark for extravascular defibrillator system
- Medtronic put volume heavy and directionally bearish
- Apple names Medtronic’s Surface as Chief People Officer, Bloomberg says
